bevacizumab,cetuximab
roche,eli lilly
['rectal', 'colorectal']
 yes, but do we need triplet therapy in first line treatment of mbraf v600e metastatic colorectal cancer?
Full Prof Medical Oncology, GI Oncologist. Gustave Roussy. Paris Saclay University. Lover of sports. Tweets are my own.